Recently, Eden announced the launch of Simeglutide chewable gummies, the world's first Simeglutide chewable gummies. This pioneering GLP-1 gummy provides the same active ingredients as compound semaglutide. Eden aims to provide the benefits of GLP-1 drugs such as semaglutide in a convenient form without needle injection, and promote personalized medication for patients. According to the information disclosed on Eden's official website, the price of Simeglutide chewable gummies includes three options: Eden President Josh Khan said, "At Eden, we are committed to making transformative healthcare services more convenient and accessible. Through this pioneering gummy candy, we eliminate barriers such as needles and discomfort, allowing individuals to explore personalized care plans with healthcare providers to achieve their health goals in a way that suits their lives.

This gummy candy is not only a pioneering product in the field, but also meets the growing demand for more convenient alternatives to traditional medicines. Research shows that 76% of people prefer oral medication over injectable medication. Eden is committed to meeting the needs of patients for a more delicious and convenient choice compared to oral semaglutide droppers.

Source: https://pharm.jgvogel.cn/c1480689.shtml